Canadian Natural Resources Limited ( CNQ:CA) Discusses Strategic Advantages, Asset Base, and Outlook at Investor Open House November 7, 2025 8:30 AM EST ...
Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback